GDPR: Important Information For Your Clinical Research The General Data Protection Regulation (GDPR) will be implemented on 25 May 2018, together with a new Data Protection Act. Read more
Bursaries for patient and public involvement in research ACCORD: Bursaries for patient and public involvement in research Read more
MHRA suspends use of certain Gadolinium contrast agents (GdCAs), and restricts uses of others MHRA suspends use of certain Gadolinium contrast agents (GdCAs), and restricts uses of others. Read more
MHRA Recall of Gadolinium-containing contrast agents A class 2 medicine recall – action within 48 hours – has now been issued by the MHRA for Magnevist (Bayer plc) and Omniscan Solution (GE Healthcare). Read more
eHealth IT Security Policy The eHealth IT Security policy is available here: http://www.accord.scot/researcher-access/ehealth-it-security-policy Read more
MHRA Statement on Lab Inspections Statement from the MHRA on inspections of Labs analysing human samples as part of a clinical trial. Read more
Management of Deviations & Violations Training Material Management of Deviations & Violations Training Materials available. Read more
